Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve advanced breast cancer
Titel:
Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve advanced breast cancer
Auteur:
Johnston, Stephen Basik, Mark Hegg, Roberto Lausoontornsiri, Wirote Grzeda, Lukasz Clemons, Mark Dreosti, Lydia Mann, Helen Stuart, Mary Cristofanilli, Massimo